Corrigendum to “Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency” [Neurobiology of Disease 149 (2021) 105224]
Chinnasamy Dhanalakshmi,
Udaiyappan Janakiraman,
Aubin Moutal,
Kohji Fukunaga,
Rajesh Khanna,
Mark A. Nelson
Affiliations
Chinnasamy Dhanalakshmi
Department of Pathology, University of Arizona College of Medicine and College of Pharmacy, Tucson, AZ, USA
Udaiyappan Janakiraman
Department of Pathology, University of Arizona College of Medicine and College of Pharmacy, Tucson, AZ, USA
Aubin Moutal
Department of Pharmacology, University of Arizona College of Medicine and College of Pharmacy, Tucson, AZ, USA; The Center for Innovation in Brain Sciences, The University of Arizona Health Sciences, Tucson, AZ, USA; The BIO5 Institute, University of Arizona, USA
Kohji Fukunaga
Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
Rajesh Khanna
Department of Pharmacology, University of Arizona College of Medicine and College of Pharmacy, Tucson, AZ, USA; The Center for Innovation in Brain Sciences, The University of Arizona Health Sciences, Tucson, AZ, USA; The BIO5 Institute, University of Arizona, USA
Mark A. Nelson
Department of Pathology, University of Arizona College of Medicine and College of Pharmacy, Tucson, AZ, USA; Corresponding author.
